P/E ratio for The Joint Corp. (JYNT)
P/E ratio as of July 2025 (TTM): -19.6
According to The Joint Corp.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -19.6207. At the end of 2024 the company had a P/E ratio of -18.6.
P/E ratio history for The Joint Corp. from 2014 to 2025
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2024 | -18.6 | 26.14% |
| 2023 | -14.8 | -111.66% |
| 2022 | 127 | -3.52% |
| 2021 | 131 | 365.28% |
| 2020 | 28.2 | -59.76% |
| 2019 | 70.2 | -71.37% |
| 2018 | 245 | |
| 2016 | -2.21 | -67.82% |
| 2015 | -6.86 | -56.91% |
| 2014 | -15.9 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 National Healthcare
NHC | 13.7 | -169.77% | 🇺🇸 USA |
 Tenet Healthcare THC | 10.3 | -152.34% | 🇺🇸 USA |
 HCA Healthcare HCA | 14.9 | -175.73% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.